GO:0031952 regulation of protein autophosphorylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031952 (regulation of protein autophosphorylation) describes any process that modulates the frequency, rate, or extent of a protein phosphorylating its own residues.
• Autophosphorylation is a key regulatory event in many protein kinases, often controlling kinase activation, substrate specificity, and downstream signaling.
• Regulation of autophosphorylation can occur through trans-phosphorylation, cofactor binding, and structural changes in the activation loop.
• Dysregulated autophosphorylation is implicated in cancer, metabolic disorders, and neurodegeneration.
• Key experimental approaches include knockout, point-mutation, and knock-in models to dissect the functional consequences of autophosphorylation.
• CRISPR-based screens and bioinformatics can identify regulators of autophosphorylation and their disease relevance.
Description
Protein autophosphorylation is a self-catalyzed phosphorylation event in which a protein kinase transfers a phosphate group from ATP to one or more of its own amino acid residues. This process is critical for the regulation of kinase activity, often serving as a molecular switch that controls downstream signaling cascades. The Gene Ontology term GO:0031952, regulation of protein autophosphorylation, encompasses any process that modulates the frequency, rate, or extent of this self-phosphorylation. Understanding this regulatory process is essential because autophosphorylation is a common mechanism for kinase activation and is tightly linked to cellular responses such as proliferation, differentiation, and stress adaptation. Research over the past decades has revealed that autophosphorylation can be regulated at multiple levels, including trans-phosphorylation by other kinases, binding of regulatory subunits or cofactors, and conformational changes in the activation loop. For example, the insulin receptor undergoes autophosphorylation upon ligand binding, which is essential for its tyrosine kinase activity and downstream metabolic signaling. Similarly, calcium/calmodulin-dependent protein kinase II (CaMKII) autophosphorylation is a hallmark of synaptic plasticity and memory formation. Dysregulation of autophosphorylation has been implicated in various diseases, including cancer, diabetes, and neurodegenerative disorders. Given its broad biological significance, researchers require reliable models to study the regulation of autophosphorylation. CRISPR-based gene editing enables the creation of knockout, point-mutation, and knock-in cell models to dissect the precise roles of autophosphorylation sites and their regulators. This article provides a comprehensive overview of GO:0031952, covering its definition, mechanisms, key genes, disease associations, and experimental strategies.
regulation of protein autophosphorylation At A Glance
| GO ID | GO:0031952 |
|---|---|
| GO term | regulation of protein autophosphorylation |
| Ontology | biological_process |
| Synonym | regulation of protein amino acid autophosphorylation |
| Major function | Modulates the frequency, rate, or extent of protein autophosphorylation, a key regulatory event in kinase activation and signaling. |
| Related processes | Protein phosphorylation, kinase activation, signal transduction. |
| Cellular context | Occurs in various cellular compartments, often at the plasma membrane or cytoplasm. |
| Disease relevance | Implicated in cancer, metabolic disorders, and neurodegeneration. |
What Is GO:0031952?
GO:0031952, regulation of protein autophosphorylation, is defined as any process that modulates the frequency, rate, or extent of the addition of a phosphate group by a protein to one or more of its own residues. In simpler terms, it covers all the ways cells control when and how much a protein phosphorylates itself, which often determines whether the protein is active or inactive.
Why Is regulation of protein autophosphorylation Important in Cell Biology?
Regulation of protein autophosphorylation is a fundamental control point in cellular signaling because it directly influences kinase activity and the propagation of signals that govern cell growth, metabolism, and survival. Many kinases require autophosphorylation for full activation, and disruptions in this process can lead to pathological conditions such as cancer, diabetes, and neurological disorders. Therefore, understanding how autophosphorylation is regulated offers insights into basic biology and provides potential targets for therapeutic intervention.
• Controls kinase activation and downstream signaling pathways.
• Essential for insulin receptor function and metabolic regulation.
• Critical for synaptic plasticity and memory through CaMKII autophosphorylation.
• Involved in cell cycle regulation via p34cdc2 kinase.
• Regulated by trans-phosphorylation and cofactor binding.
• Dysregulation linked to cancer, diabetes, and neurodegeneration.
• Target for drug discovery in kinase-driven diseases.
• Provides a mechanism for signal amplification and specificity.
• Plays a role in plant stress responses through CDPK autophosphorylation.
• Can be studied using CRISPR-based gene editing for precise functional analysis.
What Happens During regulation of protein autophosphorylation?
Initiation of autophosphorylation
In simple terms: A protein kinase starts phosphorylating itself, often after a trigger like ligand binding or conformational change.
Autophosphorylation typically begins when a kinase domain becomes catalytically competent, often following activation loop rearrangement or binding of a cofactor such as calcium/calmodulin. For example, the insulin receptor autophosphorylates upon insulin binding, which stabilizes the active conformation and enhances its kinase activity. Similarly, CaMKII autophosphorylation is triggered by calcium/calmodulin binding, leading to a sustained active state.
Regulation by trans-phosphorylation
In simple terms: Another kinase can phosphorylate the target kinase first, which then promotes its autophosphorylation.
Trans-phosphorylation by a different kinase molecule can precede and regulate autophosphorylation. In protein kinase C (PKC), trans-phosphorylation by upstream kinases is required for maturation, followed by autophosphorylation that stabilizes the active enzyme. This sequential mechanism ensures proper kinase activation and substrate specificity.
Modulation by regulatory subunits and cofactors
In simple terms: Other proteins or small molecules can bind to the kinase and change how much it autophosphorylates.
Regulatory subunits and cofactors can either enhance or inhibit autophosphorylation. For instance, cyclin binding regulates p34cdc2 kinase activity by promoting phosphorylation events, including autophosphorylation, which are necessary for cell cycle progression. In plants, calcium-dependent protein kinases (CDPKs) undergo autophosphorylation that affects their substrate-binding affinity, demonstrating a role in signal transduction.
Consequences of autophosphorylation
In simple terms: Once a protein phosphorylates itself, it can change its shape, activity, or ability to interact with other molecules.
Autophosphorylation often induces conformational changes that fully activate the kinase or create docking sites for downstream effectors. For example, autophosphorylation of the insulin receptor increases its tyrosine kinase activity toward substrates like IRS-1, propagating metabolic signals. In CaMKII, autophosphorylation at Thr286 generates a calcium-independent activity that is crucial for long-term potentiation. Dysregulation of these events can lead to disease, as seen in cancer where constitutive autophosphorylation drives uncontrolled proliferation.
Key Genes Involved in GO:0031952 regulation of protein autophosphorylation
The following genes and proteins are central to the regulation of protein autophosphorylation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Insulin receptor tyrosine kinase; autophosphorylation upon insulin binding activates metabolic signaling. | Target for diabetes and cancer research; models to study insulin resistance. |
| CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha; autophosphorylation regulates synaptic plasticity. | Key for memory and neurodegeneration studies; KO and point-mutation models. |
| CDK1 | Cyclin-dependent kinase 1 (p34cdc2); phosphorylation and autophosphorylation control cell cycle progression. | Cancer and cell cycle research; knockout and inhibitor studies. |
| PRKCA | Protein kinase C alpha; regulated by trans-phosphorylation followed by autophosphorylation. | Cancer and signaling studies; point-mutation of autophosphorylation sites. |
| CPK1 | Tobacco calcium-dependent protein kinase 1; autophosphorylation affects substrate binding. | Plant stress signaling; knockout and overexpression models. |
| EGFR | Epidermal growth factor receptor; autophosphorylation drives downstream proliferation signals. | Oncology research; widely used in drug discovery. |
| PDGFR | Platelet-derived growth factor receptor; autophosphorylation activates kinase domain. | Cancer and fibrosis models; point-mutation studies. |
| SRC | Non-receptor tyrosine kinase; autophosphorylation regulates activity. | Cancer and metastasis research; knockout and knock-in models. |
| ABL1 | Abelson kinase; autophosphorylation influences activity and oncogenic potential. | Leukemia research; targeted by imatinib. |
| AKT1 | Serine/threonine kinase; autophosphorylation modulates activity. | Cancer and metabolism studies; point-mutation models. |
| MAPK1 | Mitogen-activated protein kinase 1; autophosphorylation in regulatory loops. | Signaling research; knockout and overexpression. |
| CDK2 | Cyclin-dependent kinase 2; autophosphorylation affects cell cycle. | Cancer research; CRISPR knockout models. |
| CHEK1 | Checkpoint kinase 1; autophosphorylation in DNA damage response. | Cancer therapy research; point-mutation studies. |
| PLK1 | Polo-like kinase 1; autophosphorylation regulates mitosis. | Cancer and mitosis research; knockout and inhibitor studies. |
| AURKA | Aurora kinase A; autophosphorylation controls mitotic progression. | Cancer research; point-mutation and knockout models. |
| GRK5 | G protein-coupled receptor kinase 5; autophosphorylation regulates activity. | Cardiovascular and neurodegeneration research. |
| DYRK1A | Dual-specificity tyrosine phosphorylation-regulated kinase 1A; autophosphorylation in brain development. | Neurodevelopmental disorders; knockout models. |
| LRRK2 | Leucine-rich repeat kinase 2; autophosphorylation linked to Parkinson's disease. | Neurodegeneration research; point-mutation and knockout models. |
How Is regulation of protein autophosphorylation Regulated?
Regulation of protein autophosphorylation is itself controlled by multiple mechanisms. Upstream kinases can trans-phosphorylate the activation loop to prime autophosphorylation. Binding of regulatory proteins, such as cyclins for CDKs, can induce conformational changes that promote autophosphorylation. Cofactors like calcium/calmodulin modulate CaMKII autophosphorylation in response to calcium signals. Additionally, phosphatases counteract autophosphorylation, maintaining a dynamic balance. In disease states, mutations that disrupt these regulatory mechanisms can lead to constitutive autophosphorylation and aberrant signaling.
regulation of protein autophosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INSR | Insulin resistance, type 2 diabetes | Knockout and point-mutation cell models to study autophosphorylation sites. |
| CAMK2A | Memory deficits, neurodegeneration | Knock-in mice with phospho-deficient mutations. |
| LRRK2 | Parkinson's disease | Point-mutation knock-in models (e.g., G2019S). |
| EGFR | Non-small cell lung cancer, glioblastoma | Knockout and overexpression models for drug screening. |
| CDK1 | Cancer, cell cycle dysregulation | CRISPR knockout and inducible overexpression. |
Cancer
Dysregulated autophosphorylation of receptor tyrosine kinases such as EGFR and SRC can lead to constitutive activation of proliferative signaling pathways, contributing to tumorigenesis. Mutations that impair regulatory control often result in oncogenic activation, making these kinases prime targets for targeted therapies.
Metabolic disorders
Impaired autophosphorylation of the insulin receptor is associated with insulin resistance and type 2 diabetes. Defects in this process reduce the receptor's kinase activity, leading to decreased glucose uptake and metabolic dysregulation.
Neurodegeneration
Altered autophosphorylation of CaMKII and LRRK2 has been implicated in synaptic dysfunction and Parkinson's disease, respectively. Disrupted autophosphorylation can affect neuronal survival and plasticity, contributing to neurodegenerative pathologies.
From regulation of protein autophosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does autophosphorylation of a specific kinase drive tumor growth? | Knockout of the kinase or point mutation of autophosphorylation sites in cancer cell lines. |
| How does a disease-associated mutation affect autophosphorylation? | Knock-in of the mutant allele using CRISPR in isogenic cell lines. |
| What is the role of autophosphorylation in synaptic plasticity? | Knock-in mice with phospho-mimetic or phospho-deficient CaMKII. |
| Can autophosphorylation be targeted for therapy? | Overexpression of constitutively active kinase and testing inhibitors. |
| What regulators modulate autophosphorylation? | CRISPR library screening for modifiers of kinase activity. |
| How does autophosphorylation affect substrate binding? | Point mutations in autophosphorylation sites followed by biochemical assays. |
How to Study the regulation of protein autophosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation sites and stoichiometry | Identifying autophosphorylation sites in disease models. |
| In vitro kinase assay | Rate of autophosphorylation | Validating specific sites and testing inhibitors. |
| CRISPR knockout screen | Genes affecting autophosphorylation | Discovering regulators of kinase activity. |
| Western blot with phospho-specific antibodies | Levels of specific autophosphorylation | Confirming site-specific phosphorylation. |
| FRET biosensor imaging | Real-time autophosphorylation dynamics | Live-cell signaling studies. |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory subunits. |
| Site-directed mutagenesis | Effect of phospho-null or phospho-mimetic mutations | Functional dissection of autophosphorylation sites. |
| RNA-seq | Transcriptional changes upon autophosphorylation modulation | Pathway analysis in knockout models. |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics can identify autophosphorylation sites and quantify changes in phosphorylation status under different conditions. This method is powerful for mapping global autophosphorylation events and discovering new regulatory sites.
Kinase activity assays
In vitro kinase assays using recombinant proteins or immunoprecipitates measure the rate of autophosphorylation and the effect of mutations or inhibitors. These assays are essential for validating specific autophosphorylation events.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate autophosphorylation of a target kinase, revealing novel components of the regulatory network. Such screens are particularly useful for uncovering disease-relevant modifiers.
Live-cell imaging
FRET-based biosensors or fluorescently tagged kinases allow real-time monitoring of autophosphorylation dynamics in living cells. This approach provides spatial and temporal resolution of autophosphorylation events.
How CRISPR Can Be Used to Study GO:0031952 regulation of protein autophosphorylation
Knockout
CRISPR knockout of a kinase gene eliminates autophosphorylation entirely, allowing researchers to assess its contribution to cellular phenotypes and signaling pathways. For example, knocking out INSR in cell lines can reveal its role in insulin signaling and glucose uptake.
Point Mutation
Introducing point mutations at specific autophosphorylation sites (e.g., converting serine to alanine) via CRISPR base editing or HDR can dissect the function of individual phosphorylation events without affecting overall protein levels. This approach is ideal for studying site-specific regulation.
Knock-in
Knock-in of disease-associated mutations or phospho-mimetic variants (e.g., aspartate substitution) allows modeling of constitutive autophosphorylation and its pathological consequences. Such models are valuable for drug discovery and mechanistic studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of a kinase can amplify autophosphorylation signals, enabling the study of downstream effects and identification of interacting partners. Overexpression models are also used for high-throughput screening.
How EDITGENE Supports regulation of protein autophosphorylation Research
Researchers studying regulation of protein autophosphorylation-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of autophosphorylation regulators.
Contact EDITGENE today to design your custom CRISPR model for regulation of protein autophosphorylation research.
Frequently Asked Questions About regulation of protein autophosphorylation
What is GO:0031952?
GO:0031952 is the Gene Ontology term for regulation of protein autophosphorylation, defined as any process that modulates the frequency, rate, or extent of a protein phosphorylating its own residues.
What genes are involved in regulation of protein autophosphorylation?
Key genes include INSR, CAMK2A, CDK1, PRKCA, and CPK1, among others, which encode kinases whose autophosphorylation is regulated.
Why is autophosphorylation important?
Autophosphorylation is crucial for kinase activation, signal transduction, and cellular processes like growth, metabolism, and synaptic plasticity.
How is autophosphorylation regulated?
It can be regulated by trans-phosphorylation, cofactor binding, regulatory subunits, and phosphatases.
What diseases are associated with dysregulated autophosphorylation?
Cancer, diabetes, and neurodegenerative disorders such as Parkinson's disease are linked to abnormal autophosphorylation.
What methods are used to study autophosphorylation?
Phosphoproteomics, in vitro kinase assays, CRISPR screens, and live-cell imaging are commonly used.
Can CRISPR be used to study autophosphorylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of autophosphorylation.
What is the role of autophosphorylation in the insulin receptor?
Autophosphorylation of the insulin receptor upon insulin binding activates its tyrosine kinase activity, essential for metabolic signaling.
How does CaMKII autophosphorylation affect memory?
CaMKII autophosphorylation at Thr286 produces calcium-independent activity that is critical for synaptic plasticity and memory formation.
What are the synonyms for GO:0031952?
The synonym is regulation of protein amino acid autophosphorylation.
Conclusion
Regulation of protein autophosphorylation (GO:0031952) is a central mechanism controlling kinase activity and cellular signaling. Its dysregulation contributes to major human diseases, making it a prime target for research and therapeutic development. CRISPR-based models offer powerful tools to dissect the precise roles of autophosphorylation events and their regulators. EDITGENE provides end-to-end solutions to accelerate discoveries in this field.
References
- 1. Reinhardt R et al.. 2023. A critical evaluation of protein kinase regulation by activation loop autophosphorylation.. Elife 12 PMID: 37470698
- 2. Johnson CW et al.. 2022. Regulation of GTPase function by autophosphorylation.. Mol Cell 82(5):950-968.e14 PMID: 35202574
- 3. Lee J et al.. 1994. The insulin receptor: structure, function, and signaling.. Am J Physiol 266(2 Pt 1):C319-34 PMID: 8141246
- 4. Colbran RJ. 1992. Regulation and role of brain calcium/calmodulin-dependent protein kinase II.. Neurochem Int 21(4):469-97 PMID: 1338943
- 5. Ito T et al.. 2017. Autophosphorylation Affects Substrate-Binding Affinity of Tobacco Ca(2+)-Dependent Protein Kinase1.. Plant Physiol 174(4):2457-2468 PMID: 28637832
- 6. Nigg EA et al.. 1992. Regulation of p34cdc2 protein kinase activity by phosphorylation and cyclin binding.. Ciba Found Symp 170:72-84; discussion 84-96 PMID: 1483352
- 7. Dutil EM et al.. 1994. In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation.. J Biol Chem 269(47):29359-62 PMID: 7961910
- 8. Ohkubo Y et al.. 2016. [Regulation of Unfolded Protein Response via Protein S-nitrosylation].. Yakugaku Zasshi 136(6):801-4 PMID: 27252058
